Silver Sulfadiazine: an Antibacterial Agent for Topical use in Burns
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Plastic and Reconstructive Surgery
- Vol. 18 (1) , 119-126
- https://doi.org/10.3109/02844318409057413
Abstract
Topical antibacterial treatment is of major importance in the burn patient. Silver sulfadiazine is an effective agent with low toxicity and few side effects. Deposition of silver in tissues, and absorption of sulfadiazine are both minimal. Present and future problems are represented by the emergence of resistant Gram negative bacilli, including Pseudomonas aeruginosa. The development of related metal sulfadiazines to be used against resistant bacteria is on an investigational stage, and clinical trials are few. Silver sulfadiazine may be used in a variety of other conditions than burns.This publication has 63 references indexed in Scilit:
- Positioning, Splinting and Pressure Management of the Burned Hand: A MethodScandinavian Journal of Plastic and Reconstructive Surgery, 1984
- Leukopenia and Silver SulfadiazinePublished by Wolters Kluwer Health ,1982
- Electron-microscopic observation on silver deposition in burn wounds treated with silver sulphadiazine creamBurns, 1982
- Topical chemoprophylaxis: Trials in silver phosphate chlorhexidine, silver sulphadiazine and povidone iodine preparationsBurns, 1977
- ACUTE LEUKOPENIA AS AN ALLERGIC REACTION TO SILVER SULFADIAZINE IN BURN PATIENTSPublished by Wolters Kluwer Health ,1976
- The effect of silver compounds on the metabolism of human red cellsBurns, 1975
- In Vitro Activity of Silver Sulfadiazine against Herpesvirus hominisThe Journal of Infectious Diseases, 1975
- Silver Sulfadiazine: In Vitro Antibacterial ActivityAntimicrobial Agents and Chemotherapy, 1973
- Silver Sulfadiazine: Effect on the Ultrastructure of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1973
- Silver Sulfadiazine: Effect on the Growth and Ultrastructure of StaphylococciChemotherapy, 1973